Med-X, Inc. is in live offering mode and is actively accepting Title IV investments.
$420.00 minimum investment

Med-X, Inc.

A LEADER IN GREEN TECHNOLOGIES

Large OPO
Canoga Park, CA
Agriculture
Accepting International Investment

Welcome to Med-X, Inc.

Med-X, Inc. is an innovator and leader in developing all-natural and alternative solutions to the outdated poisonous chemicals and harmful pharmaceutical products, often used in pest control and pain management. Med-X incorporates best-in-class science and technology for manufacturing and service capabilities across pest control, pain management, aromatherapy, and essential oil product development. Commercial sales and third-party service providers are represented and managed through various domestic and international distribution partners. Retail sales are currently conducted by over-the-counter pharmacy retailers and various e-commerce service providers.


View our offering circular

A LEADER IN GREEN TECHNOLOGIES

Med-X is a leader in green technology manufacturing not only to benefit our shareholders and partners but to also help consumers and communities find solid solutions to achieve and live a healthy lifestyle without the concern of personal and environmental impact.


Med-X is further developing and expanding its digital media platform, The Marijuana Times. Med-X is developing cannabis-related products in a legal and eco-friendly fashion throughout 2018 and beyond.

EDUCATE

Inform and engage the public using digital media. Cannabis industry media is distributed via the web, mobile applications, and produced and shared social platforms like Apple News, Linkedin, YouTube, Apple Podcast and other social media outlets. Through The Marijuana Times, Med-X aims to educate and provide thoughtful and engaging content directly for the cannabis community.


INNOVATE

Develop all-natural and alternative solutions to outdated poisonous chemicals and harmful pharmaceutical products often used in pest control and pain management. Med-X innovates, researches and develops a variety of natural products that provide safe alternatives to consumers. These “Green” product lines include Nature-Cide, Thermal-Aid, Home Spa and Malibu Brands.


CULTIVATE

Research and cultivate medicinal cannabis for testing and ancillary product development when it's federally legal to do so. With patient care in mind first, in late 2015 and early 2016, Med-X followed a patient group,  while providing Nature-Cide products for cannabis cultivation for testing. We aimed to ensure that cannabis grown for medical and or recreational use was cultivated using Nature-Cide cultivation methods to ensure purity standards. This cultivation protocol led to the Nature-Cide 18-month Integrated Pest Management report. Nature-Cide is planning to enter the legal cannabis cultivation arena as soon as federal law permits.

PRODUCTS FOR A HEALTHIER YOU

COST EFFECTIVE, ALL-NATURAL PRODUCT LINE UP

NATURE-CIDE

The entire Nature-Cide line of products has 10 years of research and development behind them. All of these products have been proven effective in the field by licensed pest management professionals as well as by conducting third party laboratory efficacy tests. These products are currently being utilized for major commercial and residential use nationwide in mainstream pest control, hospitality, janitorial, transportation, and agriculture (Including cannabis cultivation). Nature-Cide is available to Pest Management Professionals through nationwide distribution such as Target Specialty Products, Univar, PCS and more!

THERMAL-AID

Thermal-Aid all-natural products are a clinically proven and patented therapeutic heating/cooling modality designed explicitly for the medical field, to reduce swelling and relieve various pain issues. Thermal-Aid products cover a wide variety of needs for patients in all age groups for a gamut of ailments including but not limited to arthritis, fibromyalgia, multiple sclerosis, migraines, back pain, and muscle aches. Thermal-Aid products can be found in various OTC pharmacy outlets and qualify for patient insurance reimbursement and FSA programs throughout the United States.

HOME SPA SHOWER SPRAY

Home Spa is a 100% natural shower spray developed using the highest quality of ingredients to simulate the aromatherapy treatments found in spas around the world. Using a unique blend of natural, therapeutic and essential oils, Home Spa was created to ease stress and clear one's mind.

PRODUCTS AND SERVICES

OVERVIEW

Med-X, Inc. has developed and currently sells numerous SKUs over three product lines. These “Green” product lines include Nature-Cide, Thermal-Aid, Home Spa and Maliblu Brands. Both the Nature-Cide and Thermal-Aid divisions hold growing relationships in large scale domestic and international distribution and have achieved this with minimal marketing dollars being expended. Home Spa products are currently selling via          e-commerce and Malibu Brands are in development.


STRATEGY

Expand market positioning with commercial advertising of the Nature-Cide product lines for continued sale in Commercial Pest Control, Hospitality, Janitorial, Transportation and Agriculture including cannabis cultivation, while preparing several SKUs for Big Box retail. Expanding our market presence of Thermal-Aid in Pain Management sectors including insurance coverage segments for Physical Therapy, Flexible Spending and Patient Care while continuing the expansion of its retail footprint within the OTC Pharmacy space.  Continue the positioning of all products that fit within consumer retail with ecommerce expansion and marketing, then market and position the Aromatherapy Home Spa brand into Big Box retail.


Company management holds licenses for various types of applications for Pest Control and is trained and proficient in several types of cultivation, including cannabis. Management is proficient in super critical extraction of all types of essential oils, and if and when the Federal Government eases rules and regulations on cannabis cultivation, sales, manufacturing and transportation, the Company is positioned to break ground on property owned by management for the use of cultivation and manufacturing of all types of cannabis related products.

SOCIAL MEDIA EXPOSURE

INDUSTY FOCUSED VIDEOS

PROVEN EFFECTIVE BY PEST CONTROL PROFESSIONALS

NATIONAL PEST CONTROL AND HEALTHCARE DISTRIBUTION

Nature-Cide is being used by a growing network of commercial customers including licensed pest control companies, like the nationally positioned PestMaster Services. Nature-Cide has also begun supplying Target Specialty Products parent company “Rentokil Initial” in various regions including Asia and India while completing set up with Univar and Pest Control Supply for national deployment.  The Company plans to continue aggressively marketing within the Pest Control, Hospitality, Transportation, Agriculture, and Janitorial supply markets, while also pursuing implementation of Nature-Cide in state and federal facilities throughout various regions in the United States.

GLOBAL PEST CONTROL AND HEALTHCARE DISTRIBUTION

PEST MANAGEMENT MARKET OVERVIEW

GLOBAL PEST CONTROL MARKET EXPECTING CONTINUED GROWTH THROUGH 2022

The global insect pest control market is projected to grow from $12.4 billion in 2016 to $17.3 billion by 2022, according to research firm MarketsandMarkets. The insect pest control market is driven by government regulations on food hygiene, public health, environmental health, and growing public awareness. The need to improve service quality for customers is expected to provide an impetus for growth in innovative pest control solutions. Lack of skilled technicians and delayed regulatory approval process for chemical products in different applications (such as residential, commercial, and industrial areas) have been considered restraining factors for the market and offer opportunities for products that fall under the less regulated FIFRA 25(b) Minimum Risk Pesticide category.

PAIN MANAGEMENT MARKET OVERVIEW

GLOBAL MARKET FOR PAIN MANAGEMENT DRUGS & DEVICES TO GROW FROM $36.6B IN 2014 TO $44.3B BY 2020

The global pain management drug market is estimated to grow from $36.6 billion in 2014 to $44.3 billion by 2020. It is anticipated to register a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period 2015-2020 according to bccResearch. Pain is a distressing sensory and emotional feeling, which occurs due to tissue damage or illness. Various diseases, such as multiple sclerosis, osteoarthritis, stomach ulcer, chronic arthritis, fibromyalgia, diabetic neuropathy, and cancer can cause pain. The duration of pain varies from short-term known as acute pain to long-term referred as chronic pain. Traditionally, the management of pain involves the reduction or treatment of pain using a particular set of drugs. Currently, 166 people die each day from an overdose by abusing prescription opiate pain medication. The need to improve service quality and safety for patients is expected to provide an impetus for growth in the pain management solution market.

DIGITAL MEDIA: THE MARIJUANA TIMES

OVERVIEW

The Marijuana Times is a thought leader in the cannabis space, especially with exposing certain blemished areas of the industry, such as the widespread unregulated chemical use by cultivators and the dangerous health impact of consuming products with high levels of synthetic chemicals.

STRATEGY

In December of 2017, Med-X announced it plans to scale up and continue expanding its media network division. The Marijuana Times News Video Show, Podcast, as well as Apple News, have the potential to broaden the reach and visibility significantly. The Marijuana Times plans to utilize its content partnerships with various players in the industry and work closely with other content partners, ad networks, and social media influences to grow its audience and increase advertising revenue.

SOCIAL MEDIA EXPOSURE

INDUSTY FOCUSED DAILY VIDEOS

PRESS

CANNABIS INDUSTRY MARKET OVERVIEW

The legalization of recreational/medical cannabis is taking over the United States. Multiple states have seen massive tax gains from legalizing recreational use while medical system states continue to be a model for other states around the country. More than half of the states in the U.S. have some medical marijuana legislation.

UNITED STATES CANNABIS LEGALIZATION

EXPECTED REVENUES ARE TOO LARGE TO IGNORE

As more states legalize medical and recreational cannabis, the demand for Med-X's quality products is growing. Innovation is where Med-X excels, and   Med-X consumer-ready products support the expansion of the industry.


State by state, new requirements for contaminant testing and product potency are affecting cultivators who handle pests and molds with harmful and toxic treatments of the past. As laws remove harmful and poisonous pesticides from the cultivation facilities and require nontoxic treatments, Nature-Cide is positioned to become an industry standard for organic pest control management.

TRACTION

Until the industry receives federal recognition and official legislation, patients and cannabis users are exposed to products that have been cultivated using the ways of the past and by cultivators interested in quantity over quality. Until there is a federal regulatory body for medical cannabis, patients and recreational users have no way to know where their product comes from or whether or not it was treated with toxic pest repellents. Patients using strains that have been treated with Med-X’s Nature-Cide green pest-control products will know their medicine is safe, even without a government stamp.


The cannabis industry has tremendous potential and our products are ready for cultivators who are looking to meet growing demand. With the commercial pest control, hospitality and janitorial venues using and recommending Nature-Cide nationally, Med-X has created a perfect jump-off point into cannabis cultivation. Management's track record with product development coupled with multiple national distribution relationships presents the opportunity for success.

Multi-state licensing is crucial to national cannabis brands finding lasting success. States are beginning to require product potency and contaminant testing to ensure consumer safety, and new laboratories are emerging to meet these needs. In 2017 Med-X released a Pest Control Cultivation Report.


Nature-Cide IPM Cannabis Cultivation Report


The landscape of cultivation is changing as licensed facilities grow in size and numbers to meet the booming medical and recreational demand for cannabis.

THE OPPORTUNITY

Now is a great time to consider investing in Med-X as we are positioned to embrace and benefit from the booming cannabis industry as well as other emerging alternative markets transitioning to green technology like the pain management and pest control industries. Ballots are heating up all over the U.S. with cannabis laws, new businesses are sprouting up to provide products and supplies. We believe we have the tools to capitalize on the massive growth of all of these industries.


The devastating effects of the opioid crisis are forcing the pharmaceutical and health care industries to take a step back and look for safer options that deliver the same results for managing pain.


Regulations make it more difficult than ever to introduce new synthetic chemical pesticides products to the market. A total social acceptance transformation is in the making in regard to folks understanding the risks and dangers associated with using chemicals in agriculture and the home.


Make history and join Med-X as we take these industries by storm. Thanks to the rapid growth of the cannabis industry and other green technology industries, new trends have developed to better support this growth.

COMPANY TIMELINE

WHY INVEST?

NEW CANNA-BUSINESS

Cannabis cultivation materials, supplies, and medical research are deemed to grow into billion-dollar industries on their own in a matter of years.


THE MARIJUANA TIMES

Our media magazine, The Marijuana Times, will draw advertisers and partners to this space in a market where many outlets block the promotion of cannabis related ads.


GREEN MEDICAL RESEARCH & DEVELOPMENT

Our research and development of medical grade strains and potencies will play a long-term role in the business model and eventually distribute cannabis to the medical community when federally legal.


CANNABIS ANCILLARY PRODUCTS

Med-X is poised to compete in the market with a tested and proven green alternative to pest control, that will meet the new state licensing standards. Cultivation centers and growers will be required to follow guidelines to deploy products such as Nature-Cide Insecticides.


FIRST TO MARKET TO EVERYONE

The industry is expanding. We have the right products, the right timing, and the right team in place to maximize our impact. We are first in the cannabis sector and green products producer to bring this opportunity to the people.


GLOBAL IMPACT

Disrupting an industry, educating the public, and providing safe and effective products for our community is our mission. We are working to make the world a better place through each and every division of our company.

We are scientists, doctors, and passionate business professionals who want to help the world and provide cleaner, safer, and more effective ways to reap the many benefits of green product development and medical cannabis.


Med-X, Inc. is already working on various stages of automation that will change the cannabis market forever and you can be a part of it today.

FREQUENTLY ASKED QUESTIONS

All Economic Value details, including future projections, employment numbers and or statistics, are sourced from The Marijuana Business Fact Book. Produced by the Marijuana Business Daily. Industry and revenue statistics are sourced from the ArcView Market Research Report.


What is Reg A+ Equity Crowdfunding?


In June 2015, the final Regulation A+ rules under Title IV of the JOBS Act of 2012 became effective, after approval by the Securities and Exchange Commission, paving the way for companies like Med-X, Inc. to raise up to $50 million from both accredited and non-accredited investors.


Med-X, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA).


THE SECURITIES OFFERED HEREBY ARE HIGHLY SPECULATIVE. INVESTING IN SHARES OF MED-X, INC. INVOLVES SIGNIFICANT RISKS.


THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT THEIR INVESTMENT IN MED-X, INC. COULD BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET CURRENTLY EXISTS FOR THE SECURITIES AND IF A PUBLIC MARKET DEVELOPS FOLLOWING THIS OFFERING IT MAY NOT CONTINUE.


MED-X, INC. 8236 REMMET AVENUE CANOGA PARK, CA 91304 - YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

VIEW OFFERING CIRCULAR HERE


THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, MED-X, INC., ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO MED-X, INC.’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. MED-X, INC. DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

In the Press

Med-X, Inc. will not be Affected Adversely by Attorney General Jeff Sessions Rescission of the Cole Memo
January 5, 2018

According to AP reports, Attorney General Jeff Sessions has rescinding the Cole Memo, which was the Obama administration's protection of state-compliant cannabis businesses that allowed for the legal cannabis industry to flourish across the country.

Med-X, Inc. leads cannabis industry in banning pesticides for truly organic weed
March 31, 2016

Med-X, Inc. has identified the use of Nature-Cide All Purpose Insecticide, its licensed, all-natural pesticide for the advanced cultivation of cannabis. Med-X, Inc. co-founder and chief operating officer, Matthew Mills, in a Criticl article, explains the advantages of their breakthrough invention.

Med-X, Inc. Resumes Equity Crowdfunding, Allows Ordinary Americans To Invest In The Cannabis Industry
October 3, 2017

Medical cannabis-focused Med-X, Inc. has resumed its Regulation A+ (Reg A+) equity crowdfunding campaign that stems from the Jobs Act of 2012. New regulations allowing regular Americans to invest in what was once reserved for only the wealthy, is now moving to Main Street.

Inside the Cannabis Industry’s First Attempt at Equity Crowdfunding
January 15, 2016

Med-X was officially founded in 2014, but co-founders Matthew Mills and Dr. David Toomey, along with Med-X board member Dr. Allan Kurtz, had been networking together since 1999, and the idea for Med-X had begun percolating as early as 2011. Explains COO Mills, “We decided when this sector started to

Med-X Enters Into Merger & Acquisition Agreement With Pacific Shore Holdings
December 23, 2017

Med-X, Inc. (Med-X) and Pacific Shore Holdings, Inc. (PSH) announced on Friday they have entered into a definitive merger and acquisition agreement. According to the Agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and cultivation services arena, will combine with PSH,

Med-X, Inc. Returns to Crowdfunding Via the StartEngine Crowdfunding Portal
September 28, 2017

LOS ANGELES, Sept. 28, 2017 /PRNewswire/ -- Med-X, Inc. (Med-X) With all regulatory matters resolved in its favor, Med-X, Inc. is pleased to announce a return to Regulation A+ equity crowdfunding via the StartEngine platform.

Med-X Inc.'s Nature-Cide Insecticide Moves into Cannabis Cultivation Supply
April 4, 2016

LOS ANGELES, April 4, 2016 /PRNewswire/ -- Med-X, Inc. announced today that its Nature-Cide products are beginning to generate revenue ahead of the company's original revenue schedule due to industry demand. Med-X, Inc. has struck a deal with cultivation distribution venue GrowMinded to supply Natur

Med-X, Inc. Enters into Merger Acquisition Agreement Capturing Multiple Revenue Streams
December 22, 2017

Med-X, Inc. ("Med-X") and Pacific Shore Holdings, Inc. ("PSH") today announced that they have entered into a definitive merger and acquisition agreement ("Agreement"). Via the Agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and cultivation services arena, will combine

Startup Med-X, Inc.‘s specialty insecticide is paving its way to becoming a leading player in the emerging $5.4 billion cannabis industry
March 23, 2016

Med-X, an LA-based enterprise that launched in 2014, has cannabis cultivators flocking to its all-natural insecticide, Nature-Cide All Purpose, for its effectiveness in killing everything from whiteflies to spider mites.

MedX’s Matthew Mills Discusses The Booming Cannabis Industry In America with Bruce Buffer
March 11, 2016

On this week’s “IT’S TIME!” show Buffer’s guest is none other than Mills and Buffer, who is the Founder of MED-X, Inc., as well as the COO, which is a company that is taking advantage of the booming Marijuana industry in the United States at full force with products that offer effective nontoxic an

Going Green Again
August 11, 2016

Pennsylvanian Greg Pettis, a 23-year-veteran of the pest control industry, is an advocate of green pesticides. But that wasn’t always so.

Med-X, Inc. Completes Merger Acquisition Agreement Capturing Multiple Revenue Streams
April 18, 2018

Med-X, Inc. ("Med-X") and Pacific Shore Holdings, Inc. ("PSH") today announced that they have completed the merger and acquisition agreement ("Agreement") announced in December 2017. Via the Agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and the cultivation services

Med-X, Inc. Engages NMS Capital Advisors as Its Exclusive Investment Banking Advisor
March 26, 2018

NMS Capital Advisors, LLC ("NMS"), a leading global focused investment banking and asset management firm, announced today that it has been engaged by Med-X, Inc. ("Med-X"). NMS will be Med-X's exclusive financial advisor and investment bank, providing financial, strategic, and M&A advisory, and inve

Help your kids get through flu season with these thermal stuffed animals
January 21, 2018

These clever stuffed animals can be heated in the microwave or cooled in the freezer to make a hot compress or provide cold relief for inflammation. Each pack comes with two animals, and the options are adorable: rabbits, bears, elephants, koalas, monkeys, and hippos are all available to satisfy

Thermal-Aid Zoo Goes Viral with Reviews, Giveaways and Consumer Demand
February 8, 2013

The Thermal-Aid Zoo is a 100% natural therapeutic, cuddly heating/cooling plush animal, specifically designed for kids, to reduce swelling, ease pain and gives kids of all ages a huggable pal year round.

Residex Professional Pest Control Distribution Signs for National Placement of Nature-Cide Products
March 17, 2016

Pacific Shore Holdings, Inc. today announced that it has taken the first steps towards national pest control distribution of its Nature-Cide products by signing a Distribution Agreement with Residex, LLC. Residex who has a national footprint in the United States with 25 distribution centers in 14 st

Med-X, Inc. and Nature-Cide Sign Leading Pest Control Company Pestmaster Services to Direct Distribution Deal
September 24, 2018

"We have been focused on using safe practices since 1979," said Van Diepen. "Nature-Cide is exactly the kind of product line our customers demand that we use. We have tested these products for months and the results are there. We have a shared culture and mission to reduce risk in our communities. T

Nature-Cide Offers New Granular Product
September 25, 2018

Nature-Cide Granular is an all-natural granular insect control for turf, lawns, bedding, exterior perimeters and additional listed locations designed to kill and deter crawling insects, including emerging larvae, while repelling rodents (including voles) and reptiles.

Thermal-Aid Zoo Releases a Miniature Collectable Version of its Popular Heating and Cooling Pack for Kids
August 8, 2013

Pacific Shore Holdings, Inc. (PSHR) introduces the New Thermal-Aid Zoo Animal "Mini's". The Thermal-Aid Zoo are a 100% natural therapeutic, cuddly heating/cooling plush animal, specifically designed for kids, to reduce swelling, ease pain and gives kids of all ages a huggable pal year round. Now you

Pacific Shore Holdings launch therapeutic, plush heating/cooling toys for kids
August 9, 2013

Pacific Shore Holdings, Inc., introduced the new Thermal-Aid Zoo animal "Mini’s". The Thermal-Aid Zoo animals are a 100% natural therapeutic, heating/cooling plush animals specifically designed for kids, to reduce swelling, ease pain and give kids of all ages a "huggable" pal year round, the company

Pacific Shore Holdings, Inc. Moves Headquarters to a 20% Larger Location in Los Angeles
October 13, 2015

Pacific Shore Holdings, Inc. (PSHR) has relocated its corporate office three miles away from its former address in Chatsworth to a 20% larger building in Canoga Park, California. The new 30,000 square foot facility is located at 8236 Remmet Ave. Canoga Park, CA 91304. The move is in response to com

Nature-Cide, a Division of Pacific Shore Holdings, Inc. to Launch New Products and Labeling at National Hardware Show in Las Vegas, NV
May 5, 2014

Pacific Shore Holdings, Inc's. (OTCBB:PSHR), Nature-Cide Division, a pest management service company that's also engaged in the manufacturing of all-natural and eco-friendly pesticides, is excited to announce that they will be attending the National Hardware Convention in Las Vegas, NV, May 6 throug

Nature-Cide Granular Insecticide
August 17, 2018

Nature-Cide Granular Insecticide is labeled for tick control, as well as for several other crawling pests and emerging larvae. The water-activated formula, which has 25(b)-exempt status, can be applied in the rain. It also can be added to fertilizer for a one-pass application on golf courses, turf,

Getting in on the Ground Floor of Cannabis Investment
December 4, 2018

This brings us to Med-X, a green technology manufacturing company that has spent the past decade developing multiple successful verticals in the mainstream health and cannabis sectors, including all-natural, environmentally conscious products for pest control, aromatherapy, pain management, and cann

Updates

Med-X, Inc. Update and 2019 Preview

11 days ago

Our COO, Matthew Mills with a quick Video Update.

As 2018 wraps up and the holiday season is now upon us, we wanted to take some time and say thank you for all of the support we have received from each and every investor that has participated in our growth. Med-X and our brands are growing rapidly because of your support and belief in our team to continue to create products that make our communities and customers safer. 

Our voices were heard this year and we look forward to carrying all the momentum into 2019 and beyond. Our Med-X family's support for safe, clean pest control practices is disrupting and opening eyes inside the Professional Pest Control Industry. Together, we hope to continue to push our mission of empowering Pest Management Professionals to seize the moment, opt for safer products and embrace the future as the entire industry begins to trend to safer products and practices. Med-X and Nature-Cide are leading the way. 

The company is positioning itself for more rapid growth in 2019. Management is already in negotiations in several international markets to exclusively sell and distribute Nature-Cide products. 

The Nature-Cide team has committed to its most expansive marketing plan to date with annual marketing and advertising commitments with all of its distributors and industry trade publications. Nature-Cide is currently one of the fastest growing pesticide brands in the industry and the team anticipates that the timing of these initiatives could not be any better with the trends the industry is seeing. 

Our investment banking team has been working for months on some really exciting opportunities for our company to increase revenue through some potential acquisition targets we feel could take us to the next level. 

The entire team is really excited for the new year and what it will bring for our company and all of our investors. We have many more things in development and we plan to keep everyone updated as they come to be. 

Happy Holidays from everyone here at Med-X, Inc.


Med-X, Inc.'s Thermal-Aid Products Win Three 2018 National Parenting Publications Awards Joining an Exclusive List of Standout Products for the Whole Family

about 1 month ago


LOS ANGELES, Nov. 2018 / Thermal-Aid, a division of Med-X, Inc., is excited to share that it has won three 2018 National Parenting Publications Awards (NAPPA) for its Thermal-Aid Zoo, Thermal-Aid Heating & Cooling Pack, and Thermal-Aid Headache Relief System.

Each year, NAPPA's independent panel of expert judges and parents stringently test and evaluate hundreds of submissions and choose only the best of the best. Products are judged on innovation, safety, quality, educational value and the degree to which they assist busy parents and families.  

About Thermal-Aid
Thermal-Aid is a division of Med-X, Inc.'s wholly owned subsidiary, Pacific Shore Holdings, Inc. based in Canoga Park, CA.  The company focuses on providing natural and safe solutions to ailments and household needs that were most commonly treated with synthetic chemicals.  The Thermal-Aid product lines are available online and at leading retailers throughout the country.  For more information, visit: https://thermalaidproducts.com/

About NAPPA 
Integrity and honesty are at the core of what NAPPA stands for. For over 28 years, the National Parenting Product Awards (NAPPA) has been ensuring that parents purchase the highest quality products that help them connect and enjoy time with their families.  NAPPA's team of independent judges, along with parent and child testers, select the best baby gear, toys, apps, games, books, music, and other family must-haves to be award winners through year-round product testing. For more information, visit www.nappaawards.com

ABOUT MED-X
Med-X, Inc. is a Nevada corporation formed in February 2014 which, through its wholly owned subsidiary, Pacific Shore Holdings, Inc., produces various products, such as the all-natural Nature-Cide pest control products that have evolved from its Nature-Cide Pest Management Service division. Pacific Shore Holdings, Inc. is also known for its patented and clinically proven Thermal-Aid hot and cold pain management modality products, which also include the Thermal-Aid Zoo and the Thermal-Aid Headache Relief System. Med-X, Inc. also supports the fast-paced, emerging cannabis industry through the company's digital magazine, The Marijuana Times, which publishes high-quality media content for the business, medical and legislative cannabis communities to generate revenue from advertisers, as well as sell industry related merchandise to consumers. The company has been involved in product development for a number of years and once the federal government allows, is ready to bring various non-psychoactive cannabidiol products to the pain management markets, as well as supplying its products to agricultural and ancillary services industries through its Nature-Cide Integrated Pest Management service division. For more information regarding Med-X, Inc. and its divisions, please visit www.medx-rx.com, www.pac-sh.com, Nature-Cide®, Thermal-Aid ® therapy packs, Thermal-Aid Zoo, Thermal-Aid Headache Relief System, Nature-Cide Cannabis Division, The Marijuana Times; email info@medx-rx.com or call 818-349-2870.

No Offer or Solicitation Securities
This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Med-X, Inc. Cautionary Statement Regarding Forward-Looking Statements
There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the risk factors, please review Med-X, Inc.'s Regulation A+ offering circular. Contact Information: Med-X, Inc. 8236 Remmet Ave, Canoga Park, California 91304, (818) 349-2870.


Nature-Cide Continues Momentum After a Busy 2018 Pestworld Tradeshow

about 2 months ago


Every year the Nature-Cide team travels to Pestworld, the worlds largest gathering of Professional Pest Control operators and companies. Service operators travel from all over the globe to meet with product companies and get educated on the new innovations in the industry. 

Our team from Nature-Cide has been attending this Tradeshow for three years and we have been updating our progress on the StartEngine platform for the past two years. 

This year the team was in Orlando and the 2018 show was very busy. 

“When we first started attending this show we were literally laughed at. People would walk up to our booth and say that a natural product will never make it in this industry. With continuous hard work we have demonstrated the ability to forge relationships with pest control operators around the country, now we are seeing those very same people congratulating us on our growth and success.” said Matthew Mills. “

“The attitude in the industry has completely flipped. We are certain that the market has turned and it has no choice but to include natural options in a major way. It is the consumer and social pressures that are forcing this industry to change. There is no question we are the top (25b) product in the market right now,” explained Matthew. 

The team met with hundreds of Professional Management Professionals, all of which had scheduled meetings in advance or already knew everything about Nature-Cide and wanted to meet the team to ask questions on how they can begin usage of the Nature-Cide brand and strategy. 

The team also met with several new large international distributors/retailers who continue to show a lot of interest in bringing in the product to new international markets, including Europe, Central America, South America, and the Carribean. 

“The opportunities the international markets bring to this is extremely exciting,” says CEO Dr. David Toomey. “Pesticide regulations overseas are much more strict than here in the U.S. They need something that works without risk factors. That is Nature-Cide. These countries are doing long studies and tests with our products and the word is spreading fast. The feedback from the tests are all positive and orders are starting to come in.”

Last week in Los Angeles we confirmed payment and prepared to ship our first order to Rentokil Initial India. They tested the products for over a year. The first P.O. was for $40K and the products will be disbursed to train the rest of the operators there.

We also got a report from our Partner, Pestmasters Services, that the Nature-Cide All-Purpose formula had been approved by LA Metro and it was now clear to be deployed on all 2,600 buses, trains, and subways. 

At the show, the new Granular Product had the most buzz around it. Everyone was very excited about this product and we look forward to our first seasonal push in the spring of 2019. 

If you want more details or specifics on the many conversations and opportunities please feel free to reach out at any time.



No Offer or Solicitation Securities 

This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Med-X, Inc. Cautionary Statement Regarding Forward-Looking Statements

There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the Risk factors, please review Med-X, Inc.'s Regulation A+ Offering Circular.

Med-X, Inc. and Nature-Cide Sign Leading Pest Control Company Pestmaster Services to Direct Distribution Deal

3 months ago

LOS ANGELES, Sept. 24, 2018 /PRNewswire/ -- Med-X, Inc.'s ("Med-X") green pesticide product division, Nature-Cide, announced today that it has signed a direct distribution deal with one of the nation's leading green-focused pest control service companies, Pestmaster Services. Pestmaster Services, innovators of "Pest Management with Environ-Mentality," has 36 franchises and operates in 15 states.

Pestmaster Services prides itself on using products with the most advanced science to effectively control target pests with either non-toxic or low-toxic EPA ratings. Its goal is to minimize the risk to humans, pets and the environment. The harmonious engagement gives the franchise owners access to support, co-branding opportunities on the trucks, and access to new products from the Nature-Cide catalog. The Nature-Cide brand will now extend its reach into more states in larger service venues like government contracts, municipalities, school districts, hospitals, and large-scale commercial facilities.

"This is a symbiotic partnership for both companies," said the COO of Med-X, Inc., Matthew Mills. "Not many companies take integrated pest management more seriously than Jeff Van Diepen and his team. Our shared obligation to serve our communities makes this a win-win. We know how our products perform and now some of the best in the business are starting to run with them."

Jeffrey Van Diepen founded Pestmaster Services in the small eastern Sierra town of Bishop, Calif., in 1979. The company was born from an earnest concern for the environment and safety, and the company has remained dedicated to providing pest management services with this idea front and center. PCT Magazine ranks Pestmaster as the no. 80 pest control company in the nation (21,000 firms).

"We have been focused on using safe practices since 1979," said Van Diepen. "Nature-Cide is exactly the kind of product line our customers demand that we use. We have tested these products for months and the results are there. We have a shared culture and mission to reduce risk in our communities. The pest control industry is changing and we have positioned Pestmaster Services to be way ahead of the curve when it comes to utilizing and promoting environmentally sound products. This is going to be a fruitful partnership."

The distribution partnership will allow Pestmaster Services to buy directly from Nature-Cide, as well as incentivize the sales channels among the 36 franchises to offer pre-mixed products directly to their customers while expanding both of the companies' footprints nationally. The partnership gives Pestmaster the ability to distribute Nature-Cide directly to its franchisees and other venues, including U.S. government contracts. Both Nature-Cide and Pestmaster Services will be attending PestWorld 2018 in Orlando, Florida., on Oct. 22nd to 26, 2018. 

ABOUT NATURE-CIDE

At Nature-Cide, we strive to provide our customers with all-natural, green, environmentally friendly and effective products for the control of insects while repelling rodents, reptiles and various birds. The Nature-Cide product line was created by a California licensed IPM (integrated pest management) service company "Nature-Cide Service". We believe that the proper way to remove and control pests from your home or business is by the continual management of your property. By using an IPM strategy, not only do pests find the property unattractive, but the use of Nature-Cide products takes the strategy a step further by driving the pests away. It is not our intention to reinvent the pest control industry, but instead to offer the pest control community a green and effective product line, with proven efficacy to kill and repel insects, as well as repel rodents, reptiles and various birds, while leaving a pleasant aroma to satisfy even the toughest critics.

The Nature-Cide line of products has 10 years of research and development behind it. All Nature-Cide products have been proven effective in the field by licensed pest management professionals, as well as by third-party laboratory efficacy tests. For more information, please visit https://nature-cide.com or email customerservice@nature-cide.com.

ABOUT MED-X

Med-X, Inc. is a Nevada corporation formed in February 2014 which, through its wholly owned subsidiary, Pacific Shore Holdings, Inc., produces various products, such as the all-natural Nature-Cide pest control products that have evolved from its Nature-Cide Pest Management Service division. Pacific Shore Holdings, Inc. is also known for its patented and clinically proven Thermal-Aid hot and cold pain management modality products, which also include the Thermal-Aid Zoo and the Thermal-Aid Headache Relief System. Med-X, Inc. also supports the fast-paced, emerging cannabis industry through the company's digital magazine, The Marijuana Times, which publishes high-quality media content for the business, medical and legislative cannabis communities to generate revenue from advertisers, as well as sell industry related merchandise to consumers. The company has been involved in product development for a number of years and once the federal government allows, is ready to bring various non-psychoactive cannabidiol products to the pain management markets, as well as supplying its products to agricultural and ancillary services industries through its Nature-Cide Integrated Pest Management service division. For more information regarding Med-X, Inc. and its divisions, please visit www.medx-rx.com, www.pac-sh.com, Nature-Cide®, Thermal-Aid ® therapy packs, Thermal-Aid Zoo, Thermal-Aid Headache Relief System, Nature-Cide Cannabis Division, The Marijuana Times; email info@medx-rx.com or call 818-349-2870.

No Offer or Solicitation Securities

This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Med-X, Inc. Cautionary Statement Regarding Forward-Looking Statements

There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the risk factors, please review Med-X, Inc.'s Regulation A+ offering circular. Contact Information: Med-X, Inc. 8236 Remmet Ave, Canoga Park, California 91304, (818) 349-2870.

Related Links

https://www.prnewswire.com/news-releases/med-x-inc-and-nature-cide-sign-leading-pest-control-company-pestmaster-services-to-direct-distribution-deal-300717968.html?tc=eml_cleartime

The Nature-Cide Team Will be Showcasing the NEW Granular and Dust to the Professional Pest Control Industry at Pestworld 2018

3 months ago

Los Angeles, CA / September 7, 2018 - The Nature-Cide team and members from the Med-X management team will be showcasing the entire Nature-Cide Product Catalog including the newly released Granular on Oct. 23rd at the Professional Pest Control Industrie's biggest trade show, Pest World 2018. 

The team will be conducting meetings with buyers and professional pest control operators the week of Oct. 23-26. The show is put on every year by the National Pest Management Association and this year will take place at the Walt Disney World Swan and Dolphin Resort in Orlando, FL. Our booth number this year is 2001. 

http://www.pestworld2018.org/

We have participated in a lot of trade shows over the years, and Pest World is by far the most productive and important for our company. As a trendsetter in the industry right now, our team is already getting a lot of attention, weeks in advance of the show. The market is changing quickly and we are in a perfect position with our products to give Professional Pest Control Operators looking for green options all the info and tools they need to bring these products to their communities.

A lot of the attention is coming from our Label on the Granular product that is listing Ticks as a pest Nature-Cide Granular is proven to eliminate. The Granular product is the only Natural Granular Product on the market proven to treat for Ticks. Ticks are a major problem pest spreading all over the US especially on the East Coast. Families can now treat their properties with a chemical free solution that also kills Ticks. There is a lot of excitement about this. 

If you are an investor living in the South East or you are in the pest control industry and planning to attend the show and would like to meet up with our team, please let us know so we can be sure to make time on the calendar. The team will be in the Orlando area from Oct. 22nd to 26th. Mark your calendars and let us know if you want to set up a personal meeting with the team. Matthew Mills and Ada Wilson will make it a priority to meet with any investor while they are there on the road. 

Pain Relief Cream Samples:

The response from our investors has been overwhelming in regards to the number of people who want to be included in the sample program. We have decided to give out samples to all investors. 

We will keep you updated as we get everything in order. We are still planning on sending them out at the End of September. We are waiting for the sample packaging to arrive in the warehouse. 

If your shipping address is different than the address we have on file when you invested please let us know so we can update our records. 

Have a good weekend.


This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Med-X, Inc. Cautionary Statement Regarding Forward-Looking Statements

There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the Risk factors, please review Med-X, Inc.'s Regulation A+ Offering Circular.


Initial Feedback on the Maliblu Brands All-Natural Pain Relief Cream is Very Positive

4 months ago

As we have been discussing over the past couple of months, the pain relief cream is getting closer to being released. We are still working on the packaging, and our goal is to have it finalized in the next month or so. We will keep you updated.

In the meantime, we have given a small number of samples of the cream to a few investors to get some feedback. Frankly, the response has been incredible. We believe we have an extraordinary product here. It is All Natural, and it works.

As part of our commitment to our community of shareholders we wanted to let you know that we are planning to offer samples to all of our investors so you can try it and share it with people you know who suffer from pain.

We are aiming to launch the sample program at the end of September. We first want to gauge investor interest.

If you are an investor and want to participate and receive a sample of the new pain relief cream and give us your feedback, please reach out to us and let us know?

We are excited about this, and we look forward to sharing a bit of the R&D process with all of our supporters.

Again, if you are an investor and want to try the cream, please reach out to us and let us know so we can start getting things prepared.

Also, the audio from Matthews interview with Jean Ginzberg was recently published via podcast for Startup Spotlight.

https://anchor.fm/startup-spotlight/episodes/Interview-with-Matthew-Mills-of-Med-X-e24biu

We wish everyone a safe and happy Labor Day weekend.


No Offer or Solicitation Securities 

This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Med-X, Inc. Cautionary Statement Regarding Forward-Looking Statements

There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the Risk factors, please review Med-X, Inc.'s Regulation A+ Offering Circular.

Matthew's interview with - Medium Magazine - Autority Magazine

4 months ago


Matthew catching up with Jean Ginzberg, #1 best-selling author, serial entrepreneur, digital marketing expert, founder of JeanGinzburg.com


In this interview, Mattew talks about what inspires him as an entrepreneur, his path to success and what he believes is important to successfully lead a company in today's ever-evolving business environment.


https://medium.com/authority-magazine/always-stay-in-control-but-not-in-charge-with-matthew-mills-e41826b6a30c

Nature-Cide Debuts New Granular Green Insecticide and Pest Repellent

4 months ago


Nature-Cide Granular is All-Natural and Made in the U.S.A., Ideal for Residential and Commercial Use

LOS ANGELES, Aug. 13, 2018 /PRNewswire/ -- Nature-Cide (https://nature-cide.com), a division of Med-X, Inc., today announced its new all-natural Granular product for turf and pest management, made in the United States, designed to kill and deter crawling insects, including ticks and emerging larvae, while safely repelling rodents, including voles, and reptiles.

Nature-Cide Granular is ideal for turf, lawns, golf courses, exterior perimeters, agricultural and animal handling buildings, and additional locations. Its light, pleasant aroma will please even the toughest of critics. Because it is water-activated, it can be applied in the rain, and be added to fertilizer for one-pass application. Its slow release provides continuous pest protection for up to 90 days.

Med-X is an innovator and leader in developing all-natural and alternative solutions to poisonous chemicals often used in in pest control, as well as pain management and other areas.

"We want to help consumers and communities find solid solutions to achieving healthy lifestyles and peace of mind with little to no environmental impact," said Dr. David Toomey, Med-X's CEO. "We believe in changing the world for the better, one neighborhood at a time."

The Nature-Cide Granular product allows the brand to now enter the expansive Professional Turf Grass sector for the first time. Professionals in this sector manage properties like local municipalities, city parks and recreation, golf courses, cemeteries and government properties.

"Interest around this product has been very exciting," says Matthew Mills, COO, and President of Med-X, Inc. "This granular product is going to give all of our current and future customers an effective green option in this very popular Granular product category. Having a safer option to treat areas like playgrounds, ball fields, public parks and other high traffic areas is a game changer", states Mills.

Sold in 20-pound bag sizes, one bag is enough to treat 5,000 square feet with either broadcast or handheld mechanical spreaders. It is available at Target Specialty Products, Univar and PCS. For more information, please visit https://nature-cide.com.

ABOUT NATURE-CIDE

At Nature-Cide, we strive to provide our customers with all-natural, green, environmentally friendly and effective products for the control of insects while repelling rodents, reptiles and various birds. The Nature-Cide product line was created by a California licensed IPM (integrated pest management) service company "Nature-Cide Service". We believe that the proper way to remove and control pests from your home or business is by the continual management of your property. By using an IPM strategy, not only do pests find the property unattractive, but the use of Nature-Cide products takes the strategy a step further by driving the pests away. It is not our intention to reinvent the pest control industry, but instead to offer the pest control community a green and effective product line, with proven efficacy to kill and repel insects, as well as repel rodents, reptiles and various birds, while leaving a pleasant aroma to satisfy even the toughest critics.

The Nature-Cide line of products has 10 years of research and development behind it. All Nature-Cide products have been proven effective in the field by licensed pest management professionals, as well as by third-party laboratory efficacy tests. For more information, please visit https://nature-cide.com or email customerservice@nature-cide.com.

ABOUT MED-X

Med-X, Inc. is a Nevada corporation formed in February 2014 which, through its wholly owned subsidiary, Pacific Shore Holdings, Inc., produces various products, such as the all-natural Nature-Cide pest control products that have evolved from its Nature-Cide Pest Management Service division. Pacific Shore Holdings, Inc. is also known for its patented and clinically proven Thermal-Aid hot and cold pain management modality products, which also include the Thermal-Aid Zoo and the Thermal-Aid Headache Relief System. Med-X, Inc. also supports the fast-paced, emerging cannabis industry through the company's digital magazine, The Marijuana Times, which publishes high-quality media content for the business, medical and legislative cannabis communities to generate revenue from advertisers, as well as sell industry related merchandise to consumers. The company has been involved in product development for a number of years and once the federal government allows, is ready to bring various non-psychoactive cannabidiol products to the pain management markets, as well as supplying its products to agricultural and ancillary services industries through its Nature-Cide Integrated Pest Management service division. For more information regarding Med-X, Inc. and its divisions, please visit www.medx-rx.com,www.pac-sh.com, Nature-Cide®, Thermal-Aid ® therapy packs, Thermal-Aid Zoo, Thermal-Aid Headache Relief System, Nature-Cide Cannabis Division, The Marijuana Times; email info@medx-rx.com or call 818-349-2870.

No Offer or Solicitation Securities

This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Med-X, Inc. Cautionary Statement Regarding Forward-Looking Statements

There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the risk factors, please review Med-X, Inc.'s Regulation A+ offering circular. Contact Information: Med-X, Inc. 8236 Remmet Ave, Canoga Park, California 91304, (818) 349-2870.

Buzz is Building in the Pest Control Community as the Nature-Cide Granular Product Nears its Official Launch

5 months ago

Canoga Park, July 27th 2018/-- Pre-Order requests are coming in daily as our long awaited and much anticipated new Nature-Cide product is nearing its official launch date. Final adjustments to packaging and shipping have been underway for a couple of weeks now. A select group of Pest Management Professionals will be obtaining the first bags in the coming weeks.



“Interest around this product has been very exciting,” says Matthew Mills, COO, and President of Med-X, Inc. “Our customers spoke, and we listened. This granular product is going to give all of our current and future customers an effective Green Option in this Granular product category. This launch gives us our first product to sell to all of our friends in the Professional Turf Management sector. These are the people who work for Public Works, Municipalities and Golf Courses. They have constantly been requesting for us to work on this product. We feel like this is going to be a big winner.”

The Nature-Cide brand of products continues to grow on a daily basis. Sample and Order requests continue to come in seven days a week from companies looking to try Nature-Cide in their everyday operations.

We are getting very positive feedback from our Professional customers who are effectively phasing out synthetic chemical products used on properties in the exchange for Nature-Cide.

Below is a sample of the kinds of feedback we are hearing. This message is from a well respected Professional Pest Control Expert Brent Towie, from Michigan.


“I have been trying out Nature-Cide for about a month now. The Pest Management and Outdoor have been awesome, so long as you have XP or Univar Masterline Poly Surfactant. I prefer Masterline over XP. I donated a mosquito and biting fly service for a neighborhood outdoor movie held on the shore of Lake Michigan. The night before, the setup crew were being eaten alive. When I arrived the morning of the event to treat, the black flies were brutal. I mixed Nature-Cide at 4 ounces per gallon with one ounce per of Masterline Poly. That evening, not one bite. Everyone stayed for the entire movie. A few commented on how pleasant the cedar smell was when they were laying on the grass. I have already picked up two new accounts because of the donation. My company logo was on the screen for a half hour before the movie starting as well as on the neighborhood association FB Page. The average home in this area is worth over 300,000. The ones on the lake are over One Million each. I WILL continue to stress test Nature-Cide.”


Professional Pest Control Expert Brent Towie, from Michigan.


This feedback represents what we are trying to do and what our mission is all about. We are impacting communities at the most local level. We are creating jobs, giving folks something to feel good about selling, protecting people from dangerous biting insects while not impacting the long-term health of the residents or the environment.

Stay tuned, for more announcements will be coming very soon as we prepare the official launch of the Granular.

No Offer or Solicitation Securities 

This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.


Med-X, Inc. Cautionary Statement Regarding Forward-Looking Statements

There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the Risk factors, please review Med-X, Inc.'s Regulation A+ Offering Circular.

Momentum Around Our Capital Positioning is Building as Management and Our Investment Banking Partner, (NMS Capital) Begin Taking Pitch Meetings with Institutional Investors

5 months ago

Canoga Park, July 13th 2018/-- As discussed in past updates, the Med-X management team, led by COO and Founder Matthew Mills and our investment banking partner, NMS Capital Advisors, continues the process of showcasing the company to larger institutional investors in the hopes of securing large-scale capital and banking relationships to propel the company.  

This is a short clip of Matthew addressing a group of business owners and investors at an event at the Four Seasons in Beverly Hills on July 12th, 2018. 


“We need to keep turning over every rock and continuing to work hard at getting in front of as many groups and investors as we can. Every time we do this we get more and more attention around the deal. Yesterday I meet with several large individual investors as well as another local capital investment group who have heard about our deal and now have begun discussions to look deeper into the details of the company's positioning. I am confident that it is only a matter of time before we find a group that is the perfect fit and will help us raise the rest of the money we need to take this to the next level by listing on an exchange.” stated Matthew Mills. 

The team is preparing and plans to continue to travel and meet with more groups as word about the deal is starting to spread in the investment community, thanks to the support by NMS Capital. 


No Offer or Solicitation Securities 

This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Med-X, Inc. Cautionary Statement Regarding Forward Looking Statements

There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. T

Video Message and Update from COO, Matthew Mills

6 months ago

In the Video below our Founder and COO Matthew Mills gives us a quick company update. 

Matthew touches on the management teams focus on continuing the capital raising efforts with our Investment banking partners, along with continuing to grow each division. Matthew highlights specific product development news and goes into his goals for the company moving forward. 


Univar is Now an Authorized Distribution Partner with Nature-Cide

7 months ago

Management recently announced that Univar, one of the largest professional pest management distribution companies in the world, is now an authorized distributor of the Nature-Cide PMP products. This partnership significantly extends Nature-Cide's reach to a large customer base in the Univar network. 

To introduce the products to the team at Univar as well as their customers, the Nature-Cide team produced a short video that explains and showcases all of the products. 

To become more familiar with the PMP (Pest Management Professional) products you can see the same video here. 



Univar and the hexagon are the property of Univar Inc., Univar USA Inc. or affiliated companies.

Med-X, Inc. Completes Merger Acquisition Agreement Capturing Multiple Revenue Streams

8 months ago

LOS ANGELES, April 18, 2018 /--Med-X, Inc. ("Med-X") and Pacific Shore Holdings, Inc. ("PSH") today announced that they have completed the merger and acquisition agreement ("Agreement") announced in December 2017.  Via the Agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and the cultivation services arena, has combined with PSH, a global green pest control service and products company and Over the Counter ("OTC") green pharmacy products supplier. This business combination will enable Med-X to continue leadership in the development of green commercial and consumer products, integrated pest management products and services, and additionally continue to develop all-natural pain management solutions.

To read the details of the completed transaction visit Med-X SEC 1-U Filing dated April 16, 2018.

"The combination of Med-X and PSH represents the next stage of our continued growth to becoming a global leader in green initiative technologies," stated Dr. David E. Toomey, Chief Executive Officer, Med-X, Inc. "With a growing international and domestic distribution partnership footprint, all of our business divisions are positioned for global growth."

Strategy

The combined company brings together best-in-class product, technology and service capabilities across media, pest control, pain management, aromatherapy and essential oil manufacturing. As a leader in green initiatives technologies, ultimately the combined company strives to help its customers achieve a higher standard with safe and responsible products leading to a better quality of life for its customers and community. Sales will be conducted via various channels including: domestic and international commercial distribution, OTC pharmacy retailers, ecommerce, and third-party service providers. The combination of Med-X and PSH creates immediate opportunities for near-term growth through enhancement of the existing product lines and services to the growing legal cannabis market and cross-selling them through our currently established media network.

The newly merged company will benefit by combining trade secrets and essential oil blending techniques for new products, advanced service solutions already proven effective in other industries, and value-added assets like patents, trademarks, intellectual property and connectivity with mainstream distributors such as Cardinal Health, Independence Medical, Univar, Target Specialty Products and Rentokil. As a result, the new company will be able to better partner with its customers inside the legal cannabis market and to help improve their overall performance and operations thereby enhancing the experience for their own customers in areas such as health, wellness, and quality of life. The combined company will position a large licensed pest control network of "Green Program" trained professionals ready to serve consumers looking to add green pest control to their homes and properties. Additionally, the expanding regulated global cannabis cultivation market presents a large opportunity for expansion of the Company's products and services.

Med-X is in the midst of a resurgence as a thought leader in the cannabis space, especially in regard to exposing certain blemished areas of the industry such as the widespread unregulated pesticide use by cultivators, and the dangerous health impacts of consuming products with high levels of synthetic chemicals. In continuing to expand industry awareness, the company announced in December of 2017, that it plans to scale up and expand its media network division, The Marijuana Times, to help promote cannabis industry leaders, especially those who deserve to be recognized for their hard work and contributions to transforming the legal cannabis business into a robust health conscious industry.

PSH has transformed from a diversified holding company to a streamlined operating company with a focused and leading green products portfolio across multiple venues including pest control, pain management, and healthy living manufacturing. PSH combines its best-in-class products with its first-class reputation and customer support. The company's core strengths include essential oil blending and manufacturing, advanced integrated pest management, pain management solutions, as well as world-class branding and marketing.

Value for Shareholders

This transaction positions the combined company to take advantage of growing the overall business of the below mentioned divisions. 

As expected, audited Consolidated Pro-Forma Financials reflect double digit revenue growth. Pro-Forma revenue grew on a consolidated basis of approximately $483,000 for fiscal year 2016 to approximately $617,000 for fiscal year 2017, a 28% increase year over year. In addition, as of completion of the merger, the Pro-Forma consolidated balance sheet reflects assets approaching the $2 million threshold. These factors seemingly position the combined company to continue to pursue entry into the public market. Upon the closing of the merger, the following divisions will be recognized under the combined company's, Med-X, Inc.'s portfolio:

Nature-Cide - Natural Insecticides / Pesticides developed and deployed in commercial pest control, janitorial, hospitality and agriculture including cannabis cultivation. Distributed globally by Target Specialty Products, Univar and Rentokil Initial.

Nature-Cide Cultivation - Large scale, regulated cannabis cultivation and cultivation services and solutions in California and other states that are ramping up for legal cannabis cultivation.

Thermal-Aid - Natural heating and cooling modalities for pain management for the entire family. Distributed domestically by Cardinal Health and Independence Medical.

The Marijuana Times - Global digital media news network.

Maliblu Brands - Organic Cannabis & Hemp derived products developed for a variety of medical conditions, including but not limited to, pain management, PTSD, and sleep disorders.

Home Spa Products - Aromatherapy spa products for personal home use.

About Med-X, Inc. 

Med-X, Inc. is a Nevada corporation formed in February 2014, which, through its wholly-owned subsidiary, Pacific Shore Holdings, Inc., produces various products such as the all-natural Nature-Cide pest control products that have evolved from its Nature-Cide Pest Management Service division. Pacific Shore Holdings, Inc. is also known for its patented and clinically proven Thermal-Aid hot and cold pain management modality products, which also include the Thermal-Aid Zoo and the Thermal-Aid Headache Relief System. Med-X, Inc. also supports the fast-paced emerging cannabis industry through the Company's digital magazine, The Marijuana Times, which publishes high quality media content for the business, medical and legislative cannabis communities to generate revenue from advertisers as well as sell industry related merchandise to consumers. The Company has been involved in product development for a number of years and is ready to bring various non-psychoactive Cannabidiol products to the pain management markets, as well as supplying its products to agricultural and ancillary services industries through its Nature-Cide Integrated Pest Management service division. For more information regarding Med-X, Inc. and its divisions, please visit www.medx-rx.com, www.pac-sh.com, Nature-Cide®, Thermal-Aid ® therapy packs, Thermal-Aid Zoo, Thermal-Aid Headache Relief System, Nature-Cide Cannabis Division, The Marijuana Times or email info@medx-rx.com or call 818-349-2870.

No Offer or Solicitation Securities 

This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Med-X, Inc. Cautionary Statement Regarding Forward Looking Statements
There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the Risk factors, please review Med-X, Inc.'s Regulation A+ Offering Circular.

Contact Information: Med-X, Inc. 8236 Remmet Ave, Canoga Park, California 91304, (818) 349-2870

Investors: info@medx-rx.com

Media: nick@medx-rx.com

Med-X, Inc. Engages NMS Capital Advisors as Its Exclusive Investment Banking Advisor

9 months ago


BEVERLY HILLS, CA / ACCESSWIRE / March 26, 2018 / NMS Capital Advisors, LLC ("NMS"), a leading global focused investment banking and asset management firm, announced today that it has been engaged by Med-X, Inc. ("Med-X"). NMS will be Med-X's exclusive financial advisor and investment bank, providing financial, strategic, and M&A advisory, and investment banking and broker-dealer services related to Med-X's overall global business and capitalization plan.

Headquartered in Los Angeles, California, Med-X is a multi-divisional proprietary green products developer and manufacturer with global distribution in commercial pest control, janitorial, hospitality, and agriculture and over-the-counter pain management with its Nature-Cide and Thermal-Aid divisions, respectively. Med-X is also developing federally legal hemp-based CBD products for natural pain management, as well as running its media division, the MJT Network, that includes the digital publication The Marijuana Times.

Trevor M. Saliba, Founder and Chairman of NMS, said, "It is exciting to take part in the industries where Med-X's products are positioning around the world. The Med-X team has been extraordinarily innovative in their mission to create products that tackle a number of everyday environmental and personal pain management issues."

Matthew Mills, President and Chief Operating Officer, stated, "This engagement with NMS will allow the company to move more rapidly with additional product launches, future innovation, while simultaneously consummating global strategic alliances. We look forward to working with the entire NMS team and capturing the enormous opportunities in front of us today."

"This engagement represents the next stage of our continued growth to become a global leader in green technologies," stated Dr. David E. Toomey, Chief Executive Officer, Med-X, Inc. "With its international and domestic distribution partnerships in place, it will allow us to align our business divisions for global growth. Through this new relationship, we will also expand our ability to further invest in and possibly acquire other companies and/or products in the green space, while continuing our development of innovative solutions for customers and increasing shareholder value," stated Dr. Toomey.

About Med-X, Inc.

Med-X, Inc. is a Nevada corporation formed in February 2014, which, through its wholly-owned subsidiary, Pacific Shore Holdings, Inc., produces various products such as the all-natural Nature-Cide pest control products that have evolved from its Nature-Cide Pest Management Service division. Pacific Shore Holdings, Inc. is also known for its patented and clinically proven Thermal-Aid hot and cold pain management modality products, which also include the Thermal-Aid Zoo and the Thermal-Aid Headache Relief System. Med-X, Inc. also supports the fast-paced emerging cannabis industry through the Company's digital magazine, The Marijuana Times, which publishes high-quality media content for the business, medical and legislative cannabis communities to generate revenue from advertisers as well as sell industry related merchandise to consumers. The Company has been involved in product development for a number of years and is ready to bring various non-psychoactive Cannabidiol products to the pain management markets, as well as supplying its products to agricultural and ancillary services industries through its Nature-Cide Integrated Pest Management service division. For more information regarding Med-X, Inc. and its divisions, please visit www.medx-rx.com, www.pac-sh.com, Nature-Cide®, Thermal-Aid ® therapy packs, Thermal-Aid Zoo, Thermal-Aid Headache Relief System, Nature-Cide Cannabis Division, The Marijuana Times or email info@medx-rx.com or call 818-349-2870.

Contact Information:

Med-X, Inc.

8236 Remmet Ave Canoga Park, California 91304

(818) 349-2870

Media:info@medx-rx.com

About NMS Capital Advisors, LLC

Founded by Trevor M. Saliba, NMS Capital Advisors, LLC is a leading full service, global focused investment banking, securities and wealth management firm headquartered in Beverly Hills, California. We provide a full array of investment banking and advisory services including debt and equity capital raising for public and private companies, mergers and acquisitions, cross-border advisory, private equity and hedge fund advisory, valuations and fairness opinions, EB-5 capital advisory, securities brokerage and other strategic advisory services. Together with our affiliated registered investment advisory firm, NMS Capital Asset Management, Inc., we offer wealth management, alternative investments, insurance and asset management services. NMS Capital Advisors was established in 2006 as a registered broker-dealer with the Securities and Exchange Commission and FINRA. For more information, please visit www.nmsadvisors.com.

Contact:

Stacey Lavender-Mayes

310-855-0020

info@nmscapital.com

SOURCE: NMS Capital Advisors, LLC


Med-X, Inc. Positions Nature-Cide for World-Wide Growth

9 months ago


LOS ANGELES, March 16, 2018 - Med-X, Inc. ("Med-X") today announced that Adamarie Wilson has been appointed Vice President of Sales for the Nature-Cide Division. Ms. Wilson comes to the Company with a 20-year track record in the pest control industry, with her last position spanning over five years at Target Specialty Products. The Nature-Cide Division has had significant growth within Target Specialty Products and its sister company Residex distribution outlets under Ms. Wilson's supervision.

"I was initially introduced to the Nature-Cide brand and its line of products in 2015, as the brand had seemingly become a social media sensation amongst pest control professionals on Facebook, LinkedIn, Twitter and Instagram. I knew I had to get involved in the brand's growth," states Ms. Wilson. In 2016 and 2017 Ms. Wilson oversaw Nature-Cide's positioning throughout the United States as well as testing protocols in Hong Kong, Macau, and Mumbai by Target Specialty Products parent company Rentokil Initial.  Matthew Mills, President of Med-X, Inc. stated: "We are very excited to turn the Nature-Cide reins over to Ms. Wilson, as we are very confident in her efforts to continue to lead and position Nature-Cide products around the world."

Over the last two years, the Nature-Cide team has been working with multiple distribution representatives in the United States and Asia and has garnered a vast professional services customer base. There is a constant and increased demand by consumers for environmentally friendly products and an aversion and lack of acceptance for the tainted traditional pest control application products of the past. "Our Nature-Cide products are used in the home, hotel rooms, grocery stores, transportation venues, parks, and zoos. Today's consumers have become increasingly educated about health concerns related to potentially toxic pesticides and their applications, and the public is demanding immediate change," states Dr. David Toomey, Chief Executive Officer, Med-X, Inc.

According to Dr. Toomey, this increased demand for healthy change has had development service teams at Nature-Cide working side by side with commercial customers from around the world. The R&D that has been performed with the Nature-Cide product line has led to the development of non-toxic, pleasantly aromatic and highly effective products. "Our product is innovative in that it is free from the pungent odors normally associated with both traditional and natural products from the past. This has been achieved by using cutting-edge blending techniques which have led our development team to meet and exceed our expectations," states Toomey.

The vast commercial pest control and turf care customer base of Target Specialty Products contains a host of professional applicators. Pest control products are commonly used in settings such as consumer food plants, hotels & resorts, medical facilities, parks & recreation centers, schools, the transportation arena, and numerous residential venues. Many consumers, in all areas of life, will experience favorable long-term results with Nature-Cide and the Nature-Cide application methods. Both Nature-Cide and Target Specialty Products management teams are strategizing and working together in a "Green Scene" initiative to meet the pressing demand of the public and lawmakers worldwide. "We are excited to have Nature-Cide products as part of our Green initiatives for 2018 and beyond," states Todd Ferguson, President of Target Specialty Products. 

About Med-X, Inc.

Med-X, Inc. is a Nevada corporation formed in February 2014 which through its wholly owned subsidiary Pacific Shore Holdings, Inc. produces various products such as the all-natural Nature-Cide pest control products that have evolved from its Nature-Cide Pest Management Service division. Pacific Shore Holdings, Inc. is also known for its patented and clinically proven Thermal-Aid hot and cold pain management modality products, which also include the Thermal-Aid Zoo and the Thermal-Aid Headache Relief System. Med-X, Inc. also supports the fast-paced emerging cannabis industry through the Company's digital magazine, The Marijuana Times, which publishes high-quality media content for the business, medical and legislative cannabis communities to generate revenue from advertisers as well as sell industry related merchandise to consumers. The Company has been involved in product development for a number of years and is ready to bring various non-psychoactive Cannabidiol products to the pain management markets, as well as supplying its products to agricultural and ancillary services industries through its Nature-Cide cultivation division. For more information regarding Med-X, Inc. and its divisions, please visit www.medx-rx.com, www.pac-sh.com, Nature-Cide®, Thermal-Aid ® therapy packs, Thermal-Aid Zoo, Thermal-Aid Headache Relief System, Nature-Cide Cannabis Division, The Marijuana Times or email info@medx-rx.com or call 818-349-2870.

No Offer or Solicitation Securities

This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the Risk factors, please review Med-X, Inc.'s Regulation A+ Offering Circular.

Contact Information: Med-X, Inc. 8236 Remmet Ave, Canoga Park, California 91304 (818) 349-2870

Investors: info@medx-rx.com

Media: info@medx-rx.com

Nature-Cide Ships First Order to Mumbai India

10 months ago

This week, our pest control division, Nature-Cide shipped it's first order to our distribution partner, Rentokill in Mumbai, India. Our continued expansion into Asian markets exemplifies the increased need for effective and safe pest control options as more countries overseas continue to restrict the use of dangerous chemicals that tend to have long-lasting negative human and environmental impacts. 

With the addition of India, the Nature-Cide product line is currently in use in the United States and Hong Kong. The next slated rollouts will be to Malaysia and Macau. As we move forward into 2018 we intend to continue to scale up operations bringing Nature-Cide to Europe, and South America. 


This was also a big week for the media division, The Marijuana Times. The team was able to come to an agreement with a mainstream ComScore Top 5 ad network partner. This arrangement puts the digital publication in a unique place as one of the only major Cannabis Media outlets to be serving mainstream digital advertising. 



The team is hopeful that with this new revenue stream the publication will continue to grow its audience and have more flexibility to market itself as one of the premier cannabis news outlets.

Thanks for your interest and continued support.

Matthew Mills
President & Founder | Med-X, Inc.

Med-X, Inc. will not be Affected Adversely by Attorney General Jeff Sessions Rescission of the Cole Memo

12 months ago

LOS ANGELES, According to AP reports, Attorney General Jeff Sessions has rescinded the Cole Memo, which was the Obama administration's protection of state-compliant cannabis businesses that allowed for the legal cannabis industry to flourish across the country.

"Given the immediate and extensive backlash from politicians across both parties, the fact that over 70% of the country is in favor of legalized marijuana and that this action only gives the Federal government discretion to prosecute, we do not see any adverse material impact to our core businesses. It's full steam ahead for Med-X." states Med-X, Inc. Founder and President Matthew Mills.

The recent Sessions memo states that the "Memorandum is intended solely as a guide."  Thus, it is not a directive and simply allows U.S. prosecutors considerable leeway in their enforcement decisions. According to Mills, Med-X firmly believes that the likelihood of widespread federal prosecutions against marijuana companies operating legally in their State is minimal. "In fact, Federal prosecuting of individuals and companies operating outside the bounds of State law is very likely to lead to higher levels of compliance and accountability within the industry, which will be beneficial to everyone in the long haul."   

According to Mills, "At this time Med-X's core business consists of an ancillary cultivation products supplier, an information network with The Marijuana Times. and completing a merger with an affiliated company with non-cannabis revenue. We do not cultivate or distribute marijuana at the present time." 

Recently Med-X announce its plan to acquire Pacific Shore Holdings, Inc. which positions Med-X with two new revenue generating divisions. The Nature-Cide division is in the fast paced all natural "Green" pest control arena with pest control services and products. "Currently Nature-Cide products are distributed and positioned nationally through Target Specialty Products distribution centers. The highly effective all-natural Nature-Cide product line is utilized by licensed pest control operators nationally for residential and commercial applications in places like hotels, school districts, hospitals, zoos and various other applications, where using traditional chemical pest control applications is just not acceptable anymore," states Mills. 

The second revenue source will be the  Thermal-Aid division, which consists of pain relief products which are distributed by Independence Medical and Cardinal Health distribution venues and are supported by national programs such as Flexible Spending Accounts for patients nationally.  In addition, there are other products on the horizon.

As explained by Med-X, Inc. Chief Executive Officer, Dr. David Toomey, "As we have been working to perfect our work in blending essential oils for natural pest control applications for the last couple of years, no one realizes that these same blending techniques have been utilized in our Pain Management product development. This has allowed Med-X to create Hemp oil derived blends for products to combat such issues as migraine headaches as well as joint and muscle pain. The first pain relief cream product was created for the clinically proven Thermal-Aid Headache Relief System and has morphed into a proprietary essential oil blend which includes Hemp oil pain relief cream product, that we expect to release in the second quarter of 2018."

"Overall, in spite of Attorney General Sessions recent actions, we are very optimistic about the cannabis sector and Med-X's current and future revenue streams." stated Mills.

Med-X, Inc. Cautionary Statement Regarding Forward Looking Statements
There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the Risk factors, please review Med-X, Inc.'s Regulation A+  Offering Circular.



Med-X, Inc. Enters into Merger Acquisition Agreement Capturing Multiple Revenue Streams

12 months ago

Happy Holidays to everyone from the Med-X, Inc. team. Today we also have a very important announcement to make. Please see the news below. It has been a big year for us. Management is very proud of our team and we are very excited for what 2018 will bring. 

Matthew Mills | President and COO

LOS ANGELES, Dec. 22, 2017/ -- Med-X, Inc. ("Med-X") and Pacific Shore Holdings, Inc. ("PSH") today announced that they have entered into a definitive merger and acquisition agreement ("Agreement").  Via the Agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and cultivation services arena, will combine with PSH, a global green pest control company and Over the Counter ("OTC") pharmacy products supplier. This business combination will create a leader in the development of commercial and consumer products, integrated pest management services and pain management solutions. The merger is expected to close during the first quarter of 2018.

To read the details of the transaction visit Med-X SEC 1-U Filing dated 12-21-17

Under the terms of the Agreement, PSH shareholders will tender two shares of common stock, in exchange for one share of Med-X common stock. The terms have been unanimously approved by both companies' Boards of Directors. 

To facilitate this transaction, Med-X majority shareholder, President and COO Matthew Mills will surrender approximately 79% of his Med-X common stock ownership. This combined with the 10% outstanding Med-X shares owned by PSH will facilitate the exchange. Once this transaction is complete with all of the PSH shareholders, Med-X shareholders will not experience any dilution with their current holdings. Upon closing of the merger, Mr. Mills will then hold approximately 14% of the outstanding common stock of the combined company. Mr. Mills will remain in control of the combined company with the issuance of preferred stock which will have only voting share rights. This will allow senior management and the Board of Directors to maintain control of the company after the merger.

"The proposed combination of Med-X and PSH represents the next stage of our continued growth to become a global leader in green medicine technologies," stated Dr. David E. Toomey, Chief Executive Officer, Med-X, Inc. "With its international and domestic distribution partnerships in place, PSH aligns with and enhances the Med-X cannabis platform and further positions all of our business divisions for global growth. Through this transaction, we will also expand our ability to further invest in or acquire other companies in the space, develop new innovative solutions for customers and increase shareholder value," stated Dr. Toomey.

"We expect this transaction, combined with our growth plans for 2018 and beyond, to propel the combined company forward.  It should also fuel our continued efforts with our Regulation A+ Crowdfunding initiative, which allows everyday Americans to participate with an investment of $420 for 700 shares in the company. This transaction should offer greater value to our shareholders, customers and employees as well open some doors within the investment banking community," explains, Med-X, Inc. President and Chief Operating Officer, Matthew Mills.

Under the terms of the proposed transaction, the businesses of Med-X and PSH will be combined under Med-X which will retain the name, "Med-X, Inc." Upon the closing of the transaction, the combined company is expected to maintain Med-X's legal domicile and headquarters in Canoga Park, CA.

Strategy

The combined company brings together best-in-class product, technology and service capabilities across media, pest control, pain management, aromatherapy and essential oil manufacturing. As a leader in Green Medicine technologies, ultimately the combined company strives to help its customers achieve a higher quality of life with safe and responsible tools to do so. Sales will be conducted by various means including, international commercial distribution, OTC pharmacy retailers, ecommerce, and third-party service providers. The combination of Med-X and PSH creates immediate opportunities for near-term growth through enhancing the existing product lines and services to the growing legal cannabis market and cross-selling them through our currently established media network, in hopes to expand the global reach for the already established brands.

The newly merged company will also benefit by combining trade secrets and essential oil blending techniques for new products, advanced service solutions already proven effective in other industries, and value-added assets like patents, trademarks, intellectual properties and connectivity with mainstream distributors like Cardinal Health, Independence Medical, Target Specialty Products and Rentokil. As a result, the new company will be able to better partner with its customers inside the legal cannabis market to help improve their overall performance and operations, enhancing the experience for their own customers in areas such as health and wellness, potentially helping patients experience a better quality of life. In addition, the combined company will position a large licensed pest control network, of trained professionals ready to serve the expanding regulated global cannabis cultivation market.

Med-X is in the midst of a resurgence as a thought leader in the cannabis space, especially in regard to exposing certain blemished areas of the industry such as the widespread unregulated pesticide use by cultivators, and the dangerous health impacts of consuming products with high levels of synthetic chemicals. In continuing to expand industry awareness, the company announced in December of 2017, that it plans to scale up and continue expanding its media network division, The Marijuana Times to help promote industry leaders who deserve to be recognized for their hard work, and healthy contributions to the transforming legal cannabis industry.

PSH has transformed from a diversified holding company to a streamlined operating company with a focused and leading green products portfolio in pest control, pain management and healthy living manufacturing. PSH combines its best-in-class products with its first-class reputation and customer support. The company's core strengths include essential oil blending and manufacturing, advanced integrated pest management, pain management solutions as well as world-class branding and marketing.

Value for Shareholders

The Management Team of Med-X and PSH consist of the same Executive personnel. The Boards of Directors consist of the same members except for one director of PSH who will be joining the combined company's Board of Directors upon the closing. This positions the combined company to not miss a step in growing the overall business of the below mentioned divisions.

Prior to the closing, Unaudited Consolidated Pro-Forma Financials prepared by Management, which are subject to change due to the audit, are anticipated to reflect double digit revenue growth. Pro-Forma revenue grew on a consolidated basis of approximately $485,000.00 for fiscal year 2016 to approximately $590,000.00 for fiscal year 2017. In addition, the Pro-Forma consolidated balance sheet is estimated to reflect assets approaching the $2 million threshold. These factors seemingly position the combined company to continue to pursue entry into the public market. Currently the company Auditors (MJF & Associates, APC) for Med-X and PSH are conducting the required annual audits. Once the Audits are concluded, a consolidated Audit Report will be issued for the merged Company.

Upon the closing of the merger, the following divisions will be recognized under the combined companies, Med-X, Inc.'s portfolio:

Nature-Cide - Natural Insecticides / Pesticides developed and deployed in commercial pest control, janitorial, hospitality and agriculture including cannabis cultivation. Distributed globally by Target Specialty Products and Rentokil.

Nature-Cide Cultivation - Large scale, regulated cannabis cultivation and cultivation services and solutions in California.

Thermal-Aid - Natural heating and cooling modalities for pain management for the entire family. Distributed domestically by Cardinal Health and Independence Medical.

The Marijuana Times - Global digital media news network.

Maliblu Brands - Organic Cannabis & Hemp derived products developed for a variety of medical conditions, including but not limited to pain Management, PTSD and sleep disorders.

Home Spa Products - Aromatherapy spa products for personal use.

About Med-X, Inc.

Med-X, Inc. is a Nevada corporation formed in February 2014 to support the fast-paced emerging cannabis industry through such activities as compound identification and extraction of the identified cannabidiol (CBD) compounds for the present medical industry demand. The company's digital magazine, The Marijuana Times, publishes quality media content for the medical cannabis community to generate revenue from advertisers as well as sell industry related merchandise to consumers. The Company has been in product development for a number of years, and is ready to bring various products to market in the cannabis pain management, agricultural and ancillary services industries through manufacturing partnerships such as Nature-Cide. For more information regarding Med-X, Inc. and its divisions, please visit http://naturecidecannabis.com, https://www.marijuanatimes.org, www.medx-rx.com, email info@medx-rx.com or call 818-349-2870.

About Pacific Shore Holdings, Inc.

PSH produces various products like the scientifically proven all natural and effective Nature-Cide insecticides, pesticides and repellant products that evolved from its Nature-Cide Pest Management Service division. PSH is also known for its clinically proven Thermal-Aid hot and cold pain management modalities products, which also include the Thermal-Aid Zoo and the Thermal-Aid Headache Relief System. For more information about Pacific Shore Holdings, Inc. and its divisions, please visit Nature-Cide®, Thermal-Aid ® therapy packs, Thermal-Aid Zoo, Thermal-Aid Headache Relief System, www.pac-sh.com, email info@pac-sh.com or call 818-998-0996.

No Offer or Solicitation Securities

This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Med-X, Inc. Cautionary Statement Regarding Forward Looking Statements

There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the Risk factors, please review Med-X, Inc.'s Regulation A+ Offering Circular.

Contact Information: Med-X, Inc. 8236 Remmet Ave, Canoga Park, California 91304
(818) 349-2870

Investors: Matt@medx-rx.com

Media: info@medx-rx.com

 

SOURCE Med-X, Inc.; Pacific Shore Holdings, Inc.



The Marijuana Times Gets Approval to Publish on Apple News

about 1 year ago

Canoga Park, CA - Med-X, Inc.’s, The Marijuana Times continued to broaden it’s reach this week. On Thursday, the editorial team received a confirmation letter indicating that Apple had reviewed it's application and approved it’s Apple News channel. Apple iPhone users can now stay up to date via the IOS Apple News App.

“We are starting to see more leniency when it comes to Marijuana Industry content being allowed across non-cannabis information platforms,” said Editor-in-Chief, Nick Phillips. “This is important because we are getting closer and closer to the day when major, non-cannabis advertisers will enter the cannabis space. When that day happens, we will be ready.”

You can find the channel by searching the Keywords, “Marijuana Times,” in the Apple News app or clicking the link below while using your iPhone.

https://apple.news/TD4m98SFWRKSr2Ri2ZG6mUQ

“2018 is going to be a big year for us,” explained, Nick. “Going into the new year we will be publishing daily, original content across several digital platforms including, web, Native IOS, Youtube Video, Apple Podcast Audio and now Apple News. We are in a wonderful position to keep scaling this up.”

As a leader in Cannabis Industry news, The Marijuana Times is looking forward to continuing to educate the community, build up its social media presence, break more stories and bring on board more industry thought leaders and reporters.

For more information on how to become a part of The Marijuana Times, email us at info@medx-rx.com. You can stay up to date on all of the platforms through the links below.

Web: https://marijuanatimes.org

IOS App: https://itunes.apple.com/us/app/the-marijuana-times/id1120744279?mt=8

Youtube: https://www.youtube.com/channel/UCqWOS0H-tVHhRUx3j41K6Ug?

Apple Podcast: https://itunes.apple.com/us/podcast/the-marijuana-times/id1317984333

Apple News: https://apple.news/TD4m98SFWRKSr2Ri2ZG6mUQ



Med-X, Inc.’s The Marijuana Times Launches Daily Video News Program

about 1 year ago


Canoga Park, CA – The Med-X, Inc. management team is proud to announce the launch of The Marijuana Times Show, a daily video show, and Apple podcast. The team at The Marijuana Times continues to present itself as a leading authority in the cannabis industry news sector. The show was developed and launched in order to increase its contributors’ visibility and offer its readers more digital options to stay up to date on everything happening in the cannabis industry.

Hosted by cannabis media veteran, Joe Klare, the video show is produced and aired daily broadcasting the most up to date information as it happens. “Our readers and now viewers wanted more options. In today’s world, it is important to broadcast your message in as many ways as possible. We feel that the video show and podcast is the natural, next evolution of The Marijuana Times,” explained Joe Klare.

The show can be viewed daily on the publication’s Youtube channel, streamed from the website, as well as watched and/or listened to on Apple Podcast. As a subscriber, the viewers of The Marijuana Times Show can now go about their lives and stay up to date at the same time.

Med-X, Inc.’s COO, Matthew Mills is pleased with the growth and progress the digital publication has made over the past few years. “We started this because we thought there needed to be a place where people of all knowledge levels could get information to help progress the industry. Our writers and team have done a stand-up job reporting and planting The Marijuana Times as a leader in this industry. We started with a website, added an IOS app and now we have a daily video and podcast to continue to expanding our reach and touching new readers.” said Mills.

The new programming also offers The Marijuana Times partners more opportunities to advertise their products and services. The team at Med-X, Inc. and The Marijuana Times aim to continue their quest to spread the truth about cannabis as well as develop new and innovative ways to reach people at the same time.

To subscribe to the show’s Youtube channel please visit, https://www.youtube.com/channel/UCqWOS0H-tVHhRUx3j41K6Ug

The show can also be found on Apple Podcast as well as watched directly from the website.

For information on how you can be a part of the show email us at info@medx-rx.com.

Management is Proud to Announce that we have Officially Raised Over $1M Total from over 900 Investors as of this Week

about 1 year ago

Everyone on the team would like to thank all of our investors for their support as it has been one heck of an adventure to get here.


We are still the only non-real estate, ancillary Cannabis company to be Qualified by the SEC to raise capital via Regulation A+.


Nobody who raises money using Regulation A+ says it's an easy task, our journey to get to this point is no different.


We are extremely proud of our team and investors for riding out the SEC suspension with such grace, getting our SEC suspension overturned in a SEC proceeding, a first of it’s kind victory,  and hitting the ground running as soon as we got the all clear to continue our capital raising efforts in September 2017. 


Thank you. Our team is more motivated than ever. 


We wanted to take this time to also update all of our current investors as well as potential investors on the Company. 


Nature-Cide continues to grow as a premiere 25(b) product used globally by commercial and residential pest control operators. The team is winding down a week long trip in Baltimore Maryland at one of the biggest pest control events in the world, PestWorld 2017. 



The Nature-Cide brand has positioned itself as one of the fastest paced and most trusted green pesticide in the pest control industry. Moving forward this impacts Med-X because more cannabis businesses are resorting to using licensed applicators. New regulations on cannabis cultivations / facilities in California and other states require reporting and many cannabis businesses are recognizing that licensed applicators already report to state and county authorities. Using a licensed pest control applicator is the fastest, safest and most efficient way to meet the state pesticide testing requirements for cannabis cultivation.  So, where are cannabis businesses going to find these licensed applicators? Through the Nature-Cide network that we have been building since 2014. 


Applicators who once were only working on commercial agriculture applications are now finding themselves protecting production and cannabis cultivation facilities all over the country. The Nature-Cide products are being used successfully in multiple states and being implemented by licensed pest control operators. 


Temporary Cannabis business licenses are scheduled to be issued to California cannabis companies as of January 1, 2018. All new regulations on pesticides and what can be used on cannabis plants and facilities will then legally go into effect. As part of those regulations no company can apply pesticides and process cannabis goods without going through rigorous testing by state and county inspectors. We are anticipating a major shake up in regards to how cultivators and manufacturers are going to be forced to properly applicate approved pesticides throughout their cultivation production and facilities. The Nature-Cide team has been working around the clock to educate pest control operators to handle the rush of cultivation sites that are going to be forced to comply with these rigorous rules and regulations. 


Our team at Med-X has been working on a video series that walks cultivators and applicators through a detailed step-by-step process that marries applicators and cultivators to be 100% compliant.  This training video series could give cultivators and licenced applicators the tools necessary to avoid all of the pesticide problems that were recognized in Colorado, Oregon and Washington. As an approved product for use on Cannabis cultivations in Washington, Colorado, Oregon and Nevada we anticipate a surge in interest around our education and solutions. 


We have worked hard during the past 10 years to get the Nature-Cide brand in this global positioning and we are seeing the results already on the Cannabis cultivation side. 


Our published 18 month research report proves that growing world class medicinal grade Cannabis without using any chemical pesticides is not only doable but if done right, yields incredible results. Link to Report


California regulators already have some of the toughest agriculture regulations in the world. Adding Cannabis to the mix, we do not see them changing their ways, in fact we anticipate the added responsibility will only increase oversight. We anticipate a lot of changes coming to the California cannabis industry over the next two years as the market matures. 


Med-X, Inc. and The Marijuana Times is hosting and sponsoring a regulatory seminar on October 30, 2017. The seminar will bring together over 70 members of the community including leadership from the Los Angeles County Fire Departments and leadership in the dispensary and extraction sectors to work through and discuss the codes and regulations the County is responsible for drafting. We are very grateful to have been selected to help educate and train the Los Angeles County Fire / Building and Safety Organizations to recognize how cultivation can be safe if done properly.

With over 65% of Los Angeles County and 1 million people residing in the unincorporated areas of the county, these building codes will impact all legal cannabis businesses in the county and safety regulations will impact all legal businesses in their jurisdiction.


Safety presentations and discussions will include: 


  • Building codes for all manufacturing facilities, indoor and outdoor cultivation

  • Extraction facilities safety requirements

  • Water usage, runoff and proper pesticide application requirements


We look forward to continuing to facilitate and bridge the gap with our local leadership and law enforcement with the local leadership in the legal cannabis space who intend to do business in Los Angeles County the correct way. 


The Marijuana Times continues to be a leading voice in the cannabis sector. In November the publication will be launching its first daily video news show. This will give our readers another way to consume daily content and stay up to speed on what is happening in the industry. 


We hope that you found this update as inspiring as we do. Our focus and excitement has never been higher since we embarked on this journey in 2014. We pledge to continue to push for fair, safe access to medicinal Cannabis, give Cannabis companies the tools they require to operate in a safe, responsible manner as well as to educate the public on the truth of what this amazing plant can offer to all of us. 


SEC Legend

The securities offered hereby are highly speculative. Investing in shares of Med-X, Inc. involves significant risks. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if a public market develops following this offering it may not continue. You should read the offering circular before making any investment.

 

Forward-Looking Statements

This email/letter may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as "expected," anticipated,"projected" and "forecasted."  Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company.  Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events. Please refer to the offering circular link.

StartEngine Live Offering FAQs

almost 3 years ago

MED-X, INC. 


Is there a cost to investing?

No, there is no fee charged to the investor at any point during or after the transaction incurred from the StartEngine platform. You pay only for the number of shares you desire to purchase. However, some banks do charge for wire transfers or international transfers.

 

Do I have an account?

If you made a reservation for shares, then you do have a StartEngine account as one is required to make a reservation. If you no longer remember the password, you can recover it by going to www.startengine.com/forgot-password and entering the email address associated with your StartEngine account. If you did not make a reservation for shares, you will need to create a StartEngine account.

 

I forgot my password, what do I do?

You can recover your password by going to www.startengine.com/forgot-password and entering your email address.  An email with a link allowing you to reset your password and login will be sent to the email address you entered. Click on the link and follow the instructions to reset your password.  If you do not see the reset password email, please check your spam folder to make sure it did not get caught by the spam filter. If you still do not get the email, please contact customer experience at
contact@StartEngine.com.

**Please note if you try to recover your password but have not set up a StartEngine account, you will not receive an email.** 


Who can invest?

Anyone can invest. In a departure from previous investment rules, the SEC now permits Regulation A (also called Reg A+) offerings to take on investors who are non-accredited as well as accredited investors.  An accredited investor is an individual who has a net worth in excess of $1MM (excluding his or her primary residence) or has had an annual income in excess of $200,000 ($300,000 if joint income) for the past two years and reasonably expects that to continue. If you are a non-accredited investor, you may invest but will be limited to investing no more than the greater of 10% of your net worth or 10% of your annual income.


Do I have to invest a specific amount?

No, you may invest any amount as long as you meet the minimum investment amount of $420 AND, if you are a non-accredited investor, the amount you invest does not exceed the greater of 10% of your net worth or 10% of your annual income.  


How much is the minimum investment?

The minimum investment amount for MED-X, INC. is $420 or 700 shares.


What is the price per share?

The price per share for the MED-X, INC. offering is $0.60 per share.


Where can I get the full financial details on the offering?

Please refer to the Offering Circular for information on the offering.  


Can I invest by writing a check?

No, we are not accepting paper checks. Please use the Automated Clearing House (ACH) transfer or wire transfer options which are integrated with the StartEngine platform.


Is using StartEngine the only way to invest in MED-X, INC.’s Reg A+ offering?

Yes, you can only purchase Reg A+ shares in MED-X, INC. through the StartEngine platform.


Can I cancel my investment?

Yes, you can cancel your investment. If you made a mistake, you will have a 24-business hour window to contact live customer service via chat to correct your submission or cancel. 

Live chat customer service hours are as follows:

Saturday - Sunday: closed

Monday - Friday 12pm-8pm EST (9am-5pm PST) 

 

What documentation/confirmation will I receive for my investment?

Investors will receive a confirmation of their investment and a subscription agreement that has been accepted by MED-X, INC. via email.

 

Who is FundAmerica and why are they involved?

MED-X, INC. will use FundAmerica Securities, an SEC registered, FINRA member and SIPC insured broker-dealer to oversee and administer the actual financial transactions to comply with state and federal regulatory requirements.


How will I know when my investment funds have been deducted from my account?

Once FundAmerica has processed the investment, funds will be deducted via ACH or through a wire transfer. Your bank account should show a payment to FundAmerica / Alliance Bank.

 

Help, I’m experiencing a problem or having trouble using the platform to invest!

For assistance with making your investment, please contact StartEngine customer support via email at contact@startengine.com, live chat on our website by clicking on the green chat widget in the lower right corner.